1 Market Overview
1.1 Product Overview and Scope of Site-Specific Drug Delivery
1.2 Classification of Site-Specific Drug Delivery by Type
1.2.1 Overview: Global Site-Specific Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Site-Specific Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Liposomal Doxorubicin
1.2.4 Liposomal Amphoteracin B
1.2.5 Liposomal Paclitaxel
1.2.6 Other
1.3 Global Site-Specific Drug Delivery Market by Application
1.3.1 Overview: Global Site-Specific Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Other
1.4 Global Site-Specific Drug Delivery Market Size & Forecast
1.5 Global Site-Specific Drug Delivery Market Size and Forecast by Region
1.5.1 Global Site-Specific Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Site-Specific Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Site-Specific Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Site-Specific Drug Delivery Market Drivers
1.6.2 Site-Specific Drug Delivery Market Restraints
1.6.3 Site-Specific Drug Delivery Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Site-Specific Drug Delivery Product and Solutions
2.1.4 Johnson & Johnson Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Site-Specific Drug Delivery Product and Solutions
2.2.4 Gilead Sciences Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Pacira
2.3.1 Pacira Details
2.3.2 Pacira Major Business
2.3.3 Pacira Site-Specific Drug Delivery Product and Solutions
2.3.4 Pacira Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pacira Recent Developments and Future Plans
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Site-Specific Drug Delivery Product and Solutions
2.4.4 Sun Pharmaceutical Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Site-Specific Drug Delivery Product and Solutions
2.5.4 Luye Pharma Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Luye Pharma Recent Developments and Future Plans
2.6 Sigma-Tau Group
2.6.1 Sigma-Tau Group Details
2.6.2 Sigma-Tau Group Major Business
2.6.3 Sigma-Tau Group Site-Specific Drug Delivery Product and Solutions
2.6.4 Sigma-Tau Group Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sigma-Tau Group Recent Developments and Future Plans
2.7 Fudan-Zhangjiang
2.7.1 Fudan-Zhangjiang Details
2.7.2 Fudan-Zhangjiang Major Business
2.7.3 Fudan-Zhangjiang Site-Specific Drug Delivery Product and Solutions
2.7.4 Fudan-Zhangjiang Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Fudan-Zhangjiang Recent Developments and Future Plans
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Site-Specific Drug Delivery Product and Solutions
2.8.4 Teva Pharmaceutical Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
2.9 CSPC
2.9.1 CSPC Details
2.9.2 CSPC Major Business
2.9.3 CSPC Site-Specific Drug Delivery Product and Solutions
2.9.4 CSPC Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 CSPC Recent Developments and Future Plans
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Site-Specific Drug Delivery Product and Solutions
2.10.4 Novartis Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis Recent Developments and Future Plans
2.11 Kingond Pharm
2.11.1 Kingond Pharm Details
2.11.2 Kingond Pharm Major Business
2.11.3 Kingond Pharm Site-Specific Drug Delivery Product and Solutions
2.11.4 Kingond Pharm Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Kingond Pharm Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Site-Specific Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Site-Specific Drug Delivery Players Market Share
3.2.2 Top 10 Site-Specific Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Site-Specific Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Site-Specific Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Site-Specific Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Site-Specific Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Site-Specific Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Site-Specific Drug Delivery Revenue by Type (2016-2026)
6.2 North America Site-Specific Drug Delivery Revenue by Application (2016-2026)
6.3 North America Site-Specific Drug Delivery Market Size by Country
6.3.1 North America Site-Specific Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Site-Specific Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Site-Specific Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Site-Specific Drug Delivery Market Size by Country
7.3.1 Europe Site-Specific Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Site-Specific Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Site-Specific Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Site-Specific Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Site-Specific Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Site-Specific Drug Delivery Revenue by Type (2016-2026)
9.2 South America Site-Specific Drug Delivery Revenue by Application (2016-2026)
9.3 South America Site-Specific Drug Delivery Market Size by Country
9.3.1 South America Site-Specific Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Site-Specific Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Site-Specific Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Site-Specific Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Site-Specific Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Site-Specific Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm
【免責事項】
https://www.globalresearch.jp/disclaimer